Candel Therapeutics, Inc. Common Stock
CADL
CADL: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
moreShow CADL Financials
Recent trades of CADL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CADL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CADL's company Twitter account
Number of mentions of CADL in WallStreetBets Daily Discussion
Recent insights relating to CADL
Recent picks made for CADL stock on CNBC
ETFs with the largest estimated holdings in CADL
Flights by private jets registered to CADL